Everkine Corporation

Everkine Corporation appears to be a private biotechnology company focused on stem cell-derived exosome therapeutics and related regenerative medicine applications. Publicly available information is very limited, and the company is most often referenced in secondary market reports listing participants in the exosome therapeutics sector rather than through a robust primary corporate presence. Based on those sources, Everkine is best characterized as an early-stage platform biotech working in extracellular vesicles/exosomes rather than a company with a clearly disclosed clinical pipeline. No verified evidence of approved products, clinical-stage assets, public listing, or acquisition was found. Because disclosure is sparse, many operational and pipeline details remain unconfirmed.